WEBULL
WebtradeDownload

National Health Investors (NHI) Expands Its Senior Housing Portfolio, Is It Still 20% Below Fair Value?

Simply Wall St · 1d ago

What the new property deal means for National Health Investors

National Health Investors (NHI) has committed US$107.7 million for six senior housing properties across Kentucky, Michigan and Tennessee, adding 443 units to its Senior Housing Operating Portfolio with Allegro Living Management operating the communities.

That property expansion lands at a time when National Health Investors’ share price has slipped, with a 30-day share price return down 7.1% and a 90-day share price return down 17.4%. Even so, the 3-year total shareholder return is up 53.5%, suggesting long-term holders have still fared much better than recent buyers.

Scan how this National Health Investors expansion compares with other real estate operators by reviewing the list of solid balance sheet and fundamentals (25 results) now under pressure or quietly holding their ground.

Recent price weakness sits opposite a fresh US$107.7 million expansion push from National Health Investors. Is the market reacting to sentiment swings, or to what this portfolio is actually worth today?

Most Popular Narrative: 20% Undervalued

Against the last close of $65.36, the most followed narrative pegs National Health Investors' fair value around $81.88, which implies a material valuation gap that this new senior housing deal plugs directly into.

The main factor that has to go right is successful reinvestment of the $560 million NHC sale proceeds and sizeable liquidity into private pay senior housing and SHOP at returns that offset higher G&A and near term FFO pressure.

The current valuation implies the market is discounting the shift toward higher SHOP exposure, the large acquisition pipeline, and secular senior housing demand in a way that leaves National Health Investors shares pricing in modest expectations relative to this narrative, which is more bullish.

See why 18 investors see National Health Investors as 20% undervalued.

Result: Fair Value of $81.88 (UNDERVALUED)

Still, weak Holiday same store NOI and sharply higher G&A costs could limit how quickly National Health Investors converts this property push into stronger FFO.

Find out about the key risks to this National Health Investors narrative.

Next Steps

Mixed signals usually create the real opportunity, and National Health Investors now has both risks flagged by investors and rewards that still attract optimism. If you want to move quickly and form your own view based on the full picture, start with the 3 key rewards and 4 important warning signs.

Looking for more ideas beyond National Health Investors?

If you stop with National Health Investors, you miss a wider set of potential opportunities that could suit your style, risk comfort, and income goals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.